HomeCancerLeukemia

Leukemia

Zanubrutinib plus Venetoclax in Therapy-Naive CLL/SLL with del(17p) and/or TP53 Mutations

Video content material above is prompted by the next questions:Please briefly talk about the most recent outcomes from the SEQUOIA Arm D trial,...

Molecular relapse after first-line intensive remedy in sufferers with CBF or NPM1-mutated acute myeloid leukemia – a FILO research

Affected person traitsBetween 01/01/2010 and 12/31/2019, 303 sufferers from 9 facilities with newly identified CBF or NPM1-mutated AML (RUNX1::RUNX1T1, 19%; CBFB::MYH11, 27%; NPM1,...

Can leukemia return after 20 years? Understanding relapses

It's attainable for leukemia to relapse after 20 years. Nevertheless, it's more likely for leukemia to relapse within the first few years after...

Hot Topics